Skip to main content
. Author manuscript; available in PMC: 2022 Oct 5.
Published in final edited form as: Sci Transl Med. 2020 Nov 11;12(569):eaay1913. doi: 10.1126/scitranslmed.aay1913

Table 4:

Associations of NFL concentrations with NIHSS at initial evaluation and at blood draw in patients with ICH from the validation cohorts

Association between NFL and NIHSS at initial evaluation Association between NFL and NIHSS at blood draw
N Unadjusted analysis Multivariable analysis1 Unadjusted analysis Multivariable analysis1
Group β (95% CI) P-value β (95% CI) P-value β (95% CI) P-value β (95% CI) P-value
Yale ICH study series 96 0.51 (0.28, 0.73) <0.001 0.52 (0.29, 0.75) <0.001 0.55 (0.28, 0.82) <0.001 0.58 (0.28, 0.89) <0.001
UPenn ICH study series
 0–12 hours from stroke to blood draw 36 0.34 (0.05, 0.63) 0.030 0.32 (−0.01, 0.65) 0.066 N/A N/A N/A N/A
 12–36 hours from stroke to blood draw 40 0.42 (0.20, 0.64) <0.001 0.42 (0.18, 0.65) 0.001 N/A N/A N/A N/A
 60–84 hours from stroke to blood draw 29 0.57 (0.24, 0.91) 0.003 0.49 (0.12, 0.85) 0.016 N/A N/A N/A N/A

β=regression coefficient; CI=confidence interval; β values, 95% CIs, and p-values result from linear regression models. β values are interpreted as the change in mean NIHSS (on the square root scale) for each doubling in NFL concentration.

1

Multivariable models were adjusted for age, sex, hypertension, diabetes, and BMI for the Yale ICH study series, and for age, sex, hypertension, and diabetes for the longitudinal UPenn ICH series. P-values < 0.0125 are considered statistically significant after correcting for multiple testing. Information was unavailable regarding NIHSS at initial evaluation (24 from the Yale ICH study series) and NIHSS at blood draw (41 from the Yale ICH study series).